MedPath

Impact of Probiotics Supplement on the Gut Microbiota in Caesarean-born Infants

Not Applicable
Conditions
Gut Microbiota
Interventions
Dietary Supplement: probiotics
Registration Number
NCT05086458
Lead Sponsor
Shanghai 10th People's Hospital
Brief Summary

The purpose of this study is to evaluate the effect of probiotics on the gut microbiota of infants born by cesarean section.

Detailed Description

This study aims to examine the impact of probiotics administration on the gut microbiota of infants born by cesarean section. Birth,14 days and 42 days data will be collected and put into analysis to provide some suggestions on the probiotics use in the clinical for the infants born by cesarean section.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Neonates born by caesarean section
Exclusion Criteria
  • Gestational weeks <37 Birth weight <2500g or ≥4000g History of asphyxia anoxia at birth With congenital metabolic diseases or hereditary diseases With gastrointestinal diseases With infectious diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dietary Supplementprobioticsthe patients in this arm will receive probiotics blend of Bifidobacterium longum, Lactobacillus acidophilus, Enterococcus faecalis for 2 weeks.
Primary Outcome Measures
NameTimeMethod
Change in gut microbiota at 14 days between no intervention and experimental group.14 days

Study the microbiota change of stool samples 14 days between no intervention group and experimental group.

Change in gut microbiota at 42 days between no intervention group and experimental group.42 days

Study the microbiota change of stool samples at 42 days between no intervention group and experimental group.

Secondary Outcome Measures
NameTimeMethod
Change in gut microbiota at birth between no intervention and experimental group.birth

Study the microbiota change of stool samples at birth between no intervention group and experimental group.

Trial Locations

Locations (1)

Rong Yang

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath